I2E has been deployed at Biogen Idec since early 2005 and is used by the library and information systems team to solve a diverse range of knowledge discovery problems across the business, in areas such as biomarker discovery, protein-disease associations and toxicology.
The technology is designed to enable the discovery of key information from large collections of text documents that would be impossible or prohibitively time-consuming to find using conventional methods.
The system's linguistic capabilities can be used interactively to extract relevant facts and relationships from unstructured text documents and present them to the user in a structured form.
Commenting on the relationship, Roger Hale, COO of Linguamatics, said, "We are delighted that Biogen Idec have chosen to extend their license."
"This confirms that I2E continues to offer exceptional performance and value across an increasing range of key application areas in the Pharmaceutical and Biotechnology industries."